Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) EBIT

Annual EBIT

-$451.22M$90.30M-25.02%

Summary

Current Value
As of today, MDGL annual EBIT is -$451.22M, down -25.02% on
Historical Performance
MDGL annual EBIT is down -86.57% over the past 3 years, and down -375.11% over the past 5 years
All-Time High Comparison
MDGL annual EBIT is currently -660.24% below its historical high of $80.54M set on
3-Year Low Comparison
MDGL annual EBIT is at its 3-year low
Sector Comparison
MDGL annual EBIT is higher than 2.71% of companies in Healthcare sector

EBIT Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual EBIT-$451.22M-25.0%-86.6%-375.1%-660.2%
Quarterly EBIT-$113.98M+2.0%-41.7%-93.9%-1014.0%
TTM EBIT-$307.49M+43.9%-12.7%-73.7%-765.8%
Price$492.00+79.5%+64.0%+331.6%+109.8%
PE Ratio-
Annual Revenue$180.13M+100.0%+100.0%+100.0%+24.9%
Annual EPS-$21.90-9.5%-49.7%-301.6%-127.0%
Annual EBITDA-$450.13M-24.9%-86.4%-374.5%-642.3%
Annual Net Income-$465.89M-24.7%-92.6%-455.0%-689.1%

EBIT Highs

MDGL Annual EBIT Highs Comparison
PeriodHighDateCurrent
3Y-$291.39MN/A-54.9%
5Y-$206.67MN/A-118.3%
All$80.54M-660.2%

EBIT Lows

MDGL Annual EBIT Lows Comparison
PeriodLowDateCurrent
3Y-$451.22Mat low
5Y-$451.22Mat low
All-$451.22Mat low

EBIT History

YearValueChange
-$451.22M-25.0%
-$360.92M-23.9%
-$291.39M-20.5%
-$241.85M-17.0%
-$206.67M-117.6%
-$94.97M-133.4%
-$40.68M-26.9%
-$32.06M-27.4%
-$25.18M-678.7%
-$3.23M+96.1%
-$83.95M+4.1%
-$87.56M-43.7%
YearValueChange
-$60.94M-34.1%
-$45.43M-23.1%
-$36.90M-145.8%
$80.54M+185.9%
-$93.71M-41.5%
-$66.22M-11.9%
-$59.15M+16.9%
-$71.18M-57.0%
-$45.35M-60.3%
-$28.29M-288.0%
-$7.29M-1,718.5%
-$401.00K-

FAQ

  • What is the current annual EBIT of MDGL?

    As of today, MDGL annual EBIT is -$451.22M

  • What is 1-year change in MDGL annual EBIT?

    MDGL annual EBIT is down -25.02% year-over-year

  • What is 3-year change in MDGL annual EBIT?

    MDGL annual EBIT is down -86.57% over the past 3 years

  • How far is MDGL annual EBIT from its all-time high?

    MDGL annual EBIT is currently -660.24% below its historical high of $80.54M set on December 31, 2009

  • How does MDGL annual EBIT rank versus sector peers?

    MDGL annual EBIT is higher than 2.71% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

EBIT Formula

EBIT = Revenue

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl